Loading
Associate Professor Dr. Wongwiwat Tassaneeyakul

Associate Professor Dr. Wongwiwat Tassaneeyakul

เภสัชเวทและพิษวิทยา,
Faculty of Pharmaceutical Sciences,
Khon Kaen University
6701525344: H-INDEX 17

Documents

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. Monitoring of cyclosporin in whole blood by reversed-phase liquid chromatography on a butyl column Tassaneeyakul, W. 1988
2. A study of major causes and types of poisoning in Khonkaen, Thailand Tassaneeyakul, W.
Reungsritrakool, W.
Sripanyawit, U.
Premkamol, A.
Prasartthong, W.
1992
3. High-performance liquid chromatographic assay for 4-nitrophenol hydroxylation, a putative cytochrome P-4502E1 activity, in human liver microsomes Tassaneeyakul, W. 1993
4. Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism Tassaneeyakul, W.
Tassaneeyakul, W.
1993
5. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2 Tassaneeyakul, W.
McManus, M.E.
Gelboin, H.V.
1993
6. Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques Tassaneeyakul, W. 1993
7. Caffeine metabolism by human hepatic cytochromes p450: Contributions of 1A2, 2E1 and 3A isoforms Tassaneeyakul, W.
McManus, M.E.
Tassaneeyakul, W.
1994
8. Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene 1 Tassaneeyakul, W.
Tassaneeyakul, W.
1996
9. Towards Understanding Cytochromes P450 Wichittra Tassaneeyakul
Wongwiwat Tassaneeyakul
Khan Kaen Khon Kaen University
1996
10. Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice Tassaneeyakul, W.
Tassaneeyakul, W.
Vannaprasaht, S.
Yamazoe, Y.
2000
11. Genetic Polymorphism of Cytochrome P450 2C19 Wichittra Tassaneeyakul
Arporn Tawalee
Wongwiwat Tassaneeyakul
2000
12. Genetic Polymorphism of Cytochrome P450 2C19 (CYP2CL9) in The Northeastern Thai Population Wichittra Tassaneeyakul
Arpom Tawalee
Veerapol Kukongviriyapan
Wongwiwat Tassaneeyakul
2000
13. Analysis of the CYP2C19 polymorphism in a North-eastern Thai population. Tassaneeyakul, W.
Tawalee, A.
Tassaneeyakul, W.
Kukongviriyapan, V.
Blaisdell, J.A.
Goldstein, J.A.
,
2002
14. Bioequivalence Study of Ceftazidime by Intramuscular Administration in Healthy Thai Volunteers Wongwiwat Tassaneeyakul
Arporn Tawalee
Watchara Boonsawat
Katcharin Phunikom
Veerapol Kukongviriyapan
Prapawadee Puapairoj
Wichittra Tassaneeyakul
2002
15. Genetic Polymorphism of Thiopurine S-Methyltransferase in a Northeastern Thai Population Somrudee Srimartpirom
Wongwiwat Tassaneeyakul
Veerapol Kukongwiriyapan
Wichittra Tassaneeyakul
2002
16. Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C. S Srimarthpirom
S Reungjui
K Chansung
A Romphurk
W Tassaneeyakul
2003
17. Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C [4] Tassaneeyakul, W.
Srimarthpirom, S.
Reungjui, S.
Chansung, G.
Romphruk, A.V.
Tassaneeyakul, W.
2003
18. Prevalence and strain distribution of HPV in cervical cancer patients of northeastern Thailand W Settheetham-Ishida
Y Singto
N Kanjanavirojkul
P Yuenyao
W Tassaneeyakul
S Luanratanakorn
C Kularbkaew
T Ishida
2003
19. Contamination of aflatoxins in herbal medicinal products in Thailand. Tassaneeyakul, W.
Porasuphatana, S.
2004
20. Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in Northeastern Thailand W Settheetham-Ishida
Y Singto
P Yuenyao
W Tassaneeyakul
N Kanjanavirojkul
T Ishida
2004
21. Thiopurine S-methyltransferase genetic polymorphism in the Thai population Srimartpirom, S
Tassaneeyakul, W
Kukongviriyapan, V
Tassaneeyakul, W
2004
22. Thiopurine S-methyltransferase polymorphism in the Thai population Tassaneeyakul, W.
Kukongviriyapan, V.
Tassaneeyakul, W.
2004
23. Assessment of the CYP1A2 & CYP2E1 activities in thalassemia patients V Kukongviriyapan
N Somparn
L Senggunprai
U Kukongviriyapan
W Tassaneeyakul
A Jetsrisuparb
2005
24. Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma A Prawan
V Kukongviriyapan
W Tassaneeyakul
C Pairojkul
V Bhudhisawasdi
2005
25. Steady-state bioequivalence study of clozapine tablet in schizophrenic patients. K Kittiwattanagul
S Vannaprasaht
J Kampan
A Tawalee
P Puapairoj
S Tiamkao
S Juthagridsada
V Kukongviriyapan
W Tassaneeyakul
2005
26. CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations. Wichittra Tassaneeyakul
Werawath Mahatthanatrakul
Kanokporn Niwatananun
Kesara Na-Bangchang
Arporn Tawalee
Nathawut Krikreangsak
Utaiwan Cykleng
Wongwiwat Tassaneeyakul
2006
27. Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2 V Kukongviriyapan
N Phromsopha
W Tassaneeyakul
U Kukongviriyapan
B Sripa
V Hahnvajanawong
V Bhudhisawasdi
2006
28. Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis Jitpimolmard, S
Sawanyawisuth, K
Morakote, N
Vejjajiva, A
Puntumetakul, M
Sanchaisuriya, K
Tassaneeyakul, W
Tassaneeyakul, W
Korwanich, N
2007
29. ALPHA-LIPOIC ACID INCREASES REACTIVE OXYGEN SPECIES GENERATION AND REDUCED GLUTATHIONE IN AFLATOXINB1-EXPOSED HEPG2 CELL LINE Nattakorn Rangsoi
Supatra Porasuphatana
Pramote Mahakunakorn
Wongwiwat Tassaneeyakul
2007
30. Bioequivalence of Clozapine Tablet in Thai Schizophrenic Patients Wichittra Tassaneeyakul
Khanogwan Kittiwattanagul
Siriporn Tiamkao
Jureeporn Kampan
Suda Vannaprasaht
Wannapa Haewdee
Prapawadee Puapairoj
Bunkerd Kongyingyoes
Wongwiwat Tassaneeyakul
2007
31. COMPARATIVE BIOAVAILABILITY OF TWO SILDENAFIL TABLET FORMULATIONS AFTER SINGLE-DOSE ADMINISTRATION IN HEALTHY THAI MALE VOLUNTEERS Sirimas Kanjanawart
Suda Vannaprasaht
Panot Tangsucharit
Dhanu Gaysornsiri
Siriporn Tiamkao
Bunkerd Kongyingyoes
Roongpet Tangrassameeprasert
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2007
32. INHIBITORY EFFECT OF THAI MEDICINAL HERBS ON HUMAN CYTOCHROME P450 ACTIVITIES Wichittra Tassaneeyakul
Weeraya Dumrongsakunchai
Vichien Attakornvattana
Aimon Somanabandhu
Suda Vannaprasaht
Wongwiwat Tassaneeyakul
2007
33. THIOPURINE S-METHYLTRANSFERASE POLYMORPHISM AS A PREDICTIVE MARKER FOR AZATHIOPRINE-INDUCED HEMATOTOXICITY IN KIDNEY TRANSPLANT RECIPIENTS Susothorn Angsuthum
Wichittra Tassaneeyakul
Cholatip Pongskul
Dhavee Sirivongs
Wongwiwat Tassaneeyakul
Yingyos Avihingsanon
Suda Vannaprasaht
2007
34. Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism U. Boonsrirat
S. Angsuthum
S. Vannaprasaht
J. Konapurivijit
N. Hirankarn
W. Tassaneeyakul
Y. Avihingsanon
2008
35. Comparative bioavailability of two sertraline tablet formulations after single-dose administration in healthy Thai volunteers W. Tassaneeyakul
S. Kanchanawat
D. Gaysonsiri
S. Vannaprasath
R. Paupairoj
K. Kittiwattanagul
S. K. Tippabhotla
A. Khuroo
B. K. Panigrahy
S. Reyar
T. Monif
2008
36. Herb and Drug Interaction Wichittra Tassaneeyakul
Weeraya Dumrongsakunchai
Wongwiwat Tassaneeyakul
2008
37. Bioequivalence study of two meloxicam tablet formulations after single-dose administration in healthy Thai male volunteers P. Tangsucharit
J. Kampan
S. Kanjanawart
D. Gaysonsiri
S. Vannaprasaht
S. Tiamkao
K. Phunikhom
S. Simasathiansophon
P. Puapairoj
W. Tassaneeyakul
2009
38. Impact of the Heterozygous TPMT*1/*3C Genotype on Azathioprine-Induced Myelosuppression in Kidney Transplant Recipients in Thailand Vannaprasaht, S.
Angsuthum, S.
Avihingsanon, Y.
Sirivongs, D.
Pongskul, C.
Makarawate, P.
Tassaneeyakul, W.
Tassaneeyakul, W.
2009
39. Inhibition- and Mechanism-based Inactivation of Human CYP3A4 BY Phyllanthus amarus Theerada Taesotikul
Aimon Somanabandhu
Vichien Navinpipatana
Sirimas Kanjanawart
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2009
40. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population Tassaneeyakul, W
Jantararoungtong, T
Chen, P
Lin, PY
Tiamkao, S
Khunarkornsiri, U
Chucherd, P
Konyoung, P
Vannaprasaht, S
Choonhakarn, C
Pisuttimarn, P
Sangviroon, A
Tassaneeyakul, W
2009
41. Study on Cytotoxicity and Genotoxicity of Repeatedly Fried Cooking Oils by Cell Culture Jetana Weerakul
Wongwiwat Tassaneeyakul
Pramote Mahakunakorn
Supattra Porasuphatana
2009
42. Allopurinol -induced severe cutaneous adverse drug reactions in a Thai population is strongly associated with HLA-B*5801 Wongwiwat Tassaneeyakul
Somsak Tiamkao
Napat Prabmeechai
Thawinee Jantararoungtong
Pei Chen
Pao-Yu Lin
Pansu Chumworathayi
Usanee Khunarkornsiri
Parinya Konyoung
Pachadaporn Chucherd
Suda Vannaprasaht
Charoen Choonhakarn
Alisara Sangviroon
Wichittra Tassaneeyakul
2010
43. Comparative bioavailability of two risperidone orodispersible tablet products after single dose administration W. Tassaneeyakul
S. Kumar
D. Gaysonsiri
T. Kaewkamson
A. Khuroo
P. Tangsucharit
K. Phunikhom
S. Vannaprasaht
S. Kanjanawart
N. Rao Thudi
R. Jain
S. Reyar
T. Monif
2010
44. THIOPURINE S- METHYLTRANSFERASE PHARMACOGENETICS: FUNCTIONAL CHARACTERIZATION OF A NOVEL RAPIDLY DEGRADED VARIANT ALLOZYME. Q. Feng
S. Vannaprasaht
Y. Peng
S. Angsuthum
Y. Avihingsanon
V. C. Yee
W. Tassaneeyakul
R. M. Weinshilboum
2010
45. WHAT COST OF HLA-B*5801 GENOTYPING WOULD BE COST-EFECTIVE FOR THE PREVENTION OF ALLOPURINOL-INDUCED STEVENS JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS IN THAILAND: ANALYSES USING A DECISION-ANALYTIC MODEL R. Somkrua
N. Chaiyakunapruk
W. Tassaneeyakul
2010
46. Comparative bioavailability of two sildenafil tablet formulations after single-dose administration in healthy Thai male volunteers S. Kanjanawart
D. Gaysonsiri
P. Tangsucharit
S. Vannaprasaht
K. Phunikhom
T. Kaewkamson
N. Wattanachai
W. Tassaneeyakul
2011
47. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases N. Namwat
J. Puetkasichonpasutha
W. Loilome
P. Yongvanit
A. Techasen
A. Puapairoj
B. Sripa
W. Tassaneeyakul
N. Khuntikeo
S. Wongkham
2011
48. Inhibitory effects of Phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: evidence for CYP3A4 mechanism-based inhibition. Theerada Taesotikul
Weeraya Dumrongsakulchai
Nitsupa Wattanachai
Vichien Navinpipat
Aimon Somanabandhu
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2011
49. In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: Effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance Wattanachai, N
Polasek, TM
Heath, TM
Uchaipichat, V
Tassaneeyakul, W
Tassaneeyakul, W
Miners, JO
2011
50. EVIDENCE SYNTHESIS OF ASSOCIATION OF HLA-B*1502 ALLELE AND CARBAMAZEPINE -INDUCED STEVENS JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS: A SYSTEMATIC REVIEW W. Tangamornsuksan
N. Chaiyakunapruk
R. Somkrua
M. Lohitnavy
W. Tassaneeyakul
2012
51. Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing M. S. Hershfield
J. T. Callaghan
W. Tassaneeyakul
T. Mushiroda
C. F. Thorn
T. E. Klein
M. T. M. Lee
2013
52. SCN5A (H558R) gene mutation is associated with appropriate shock therapy in Thai Brugada syndrome patients receiving AICD treatment P. Makarawate
N. Chaosuwannakit
S. Vannaprasaht
K. Sawanyawisuth
K. Seok Hwee
E. Deoon Lee
W. Tassaneeyakul
2013
53. Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions. Thachanan Kongpan
Surakameth Mahasirimongkol
Parinya Konyoung
Sirimas Kanjanawart
Pansu Chumworathayi
Nuanjun Wichukchinda
Runglak Kidkeukarun
Suphanlinee Preechakul
Usanee Khunarkornsiri
Warawut Bamrungram
Butsaban Supharatwattanakun
Piroon Mootsikapun
Supanida Kwangsukstid
Sukanda Denjanta
Suda Vannaprasaht
Watcharee Rungapiromnan
Wimon Suwankesawong
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2015
54. Genetic Determinants of Antiplatelet Aggregation Response to Clopidogrel Under Steady State Condition N. Nakkam
S. Kanjanawart
S. Tiamkao
W. Tassaneeyakul
2015
55. Genetic Markers for Severe Cutaneous Adverse Drug Reactions of Phenytoin S. Tiamkao
N. Prabmeechai
P. Konyoung
P. Chumworathayi
C. Sukasem
T. Kongpan
N. Saksit
A. Sangviroon
S. Vannaprasath
S. Kanjanawat
N. Wichukchinda
S. Mahasirimongkol
W. Inunchot
N. Chaiyakunapruk
W. Tassaneeyakul
2015
56. The Effect of Genetic Polymorphism of CYP2C9 on Phenytoin Dosage Requirement in Thai Epileptic Patients S. Vannaprasaht
P. Sirisawat
P. Chiewthanakul
S. Tiamkao
W. Tassaneeyakul
2015
57. The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions. Nontaya Nakkam
Somsak Tiamkao
Sirimas Kanjanawart
Siriporn Tiamkao
Suda Vannaprasaht
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2015
58. Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population Tassaneeyakul, W.
Kongpan, T.
Chumworathayi, P.
Tiamkao, S.
Nakkam, N.
Vannaprasaht, S.
Mahasirimongkol, S.
Tassaneeyakul, W.
2016
59. Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers Tassaneeyakul, W.
Nakkam, N.
Tiamkao, S.
Kanjanawart, S.
Phunikhom, K.
Tiamkao, S.
Vannaprasaht, S.
Tassaneeyakul, W.
2017
60. Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers
. Nakkam, N
Tiamkao, S
Kanjanawart, S
Phunikhom, K
Tiamkao, S
Vannaprasaht, S
Tassaneeyakul, W
Tassaneeyakul, W
2017
61. Comparison between the HLA-B*58: 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions Niwat Saksit
Nontaya Nakkam
Parinya Konyoung
Usanee Khunarkornsiri
Wongwiwat Tassaneeyakul
Pansu Chumworathayi
Sirimas Kanjanawart
Chonlaphat Sukasem
Alisara Sangviroon
Oranuch Pattanacheewapull
Wichittra Tassaneeyakul
2017
62. CYP2C9*3 VARIANT IS ASSOCIATED WITH PHENYTOIN-RELATED SEVERE CUTANEOUS ADVERSE REACTIONS IN A THAI POPULATION Wichittra Tassaneeyakul
Parinya Konyoung
Thachanan Kongpan
Pansu Chumworathayi
Nontaya Nakkam
Suda Vannaprasaht
Somsak Tiamkao
Chonlaphat Sukasem
Patompong Satapornpong
Wongwiwat Tassaneeyakul
2017
63. Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population Saksit, N
Tassaneeyakul, W
Nakkam, N
Konyoung, P
Khunarkornsiri, U
Chumworathayi, P
Sukasem, C
Suttisai, S
Piriyachananusorn, N
Tiwong, P
Chaiyakunapruk, N
Sawanyawisuth, K
Rerkpattanapipat, T
Tassaneeyakul, W
2017
64. HLA Pharmacogenetic Markers o Drug Hypersensitivity in a Thai Population Nontaya Nakkam
Parinya Konyoung
Sirimas Kanjanawart
Niwat Saksit
Thachanan Kongpan
Kanyarat Khaeso
Usanee Khunarkornsiri
Areerat Domsena
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2018
65. HLA pharmacogenetic markers of drug hypersensitivity in a Thai population Nakkam, N
Kanjanawart, S.
Kongpan, T.
Tassaneeyakul, W.
2018
66. Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population. Nakkam, N
Konyoung, P
Kanjanawart, S
Saksit, N
Kongpan, T
Khaeso, K
Khunarkornsiri, U
Dornsena, A
Tassaneeyakul, W
Tassaneeyakul, W
2018
Count 24 17 44 8

Title Authors Year Publication name Cited count
< 2015 2016 2017 2018 2019 2020 Total
1. Monitoring of cyclosporin in whole blood by reversed-phase liquid chromatography on a butyl column Tassaneeyakul, W. 1988 Journal of Chromatography B: Biomedical Sciences and Applications
C (427), pp. 195-198
2. A study of major causes and types of poisoning in Khonkaen, Thailand Tassaneeyakul, W.
Reungsritrakool, W.
Sripanyawit, U.
Premkamol, A.
Prasartthong, W.
1992 Veterinary and Human Toxicology
6 (34), pp. 489-492
3. High-performance liquid chromatographic assay for 4-nitrophenol hydroxylation, a putative cytochrome P-4502E1 activity, in human liver microsomes Tassaneeyakul, W. 1993 Journal of Chromatography B: Biomedical Sciences and Applications
1 (616), pp. 73-78
4. Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism Tassaneeyakul, W.
Tassaneeyakul, W.
1993 British Journal of Clinical Pharmacology
6 (36), pp. 521-530
5. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2 Tassaneeyakul, W.
McManus, M.E.
Gelboin, H.V.
1993 Journal of Pharmacology and Experimental Therapeutics
1 (265), pp. 401-407
6. Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques Tassaneeyakul, W. 1993 Biochemical Pharmacology
11 (46), pp. 1975-1981
7. Caffeine metabolism by human hepatic cytochromes p450: Contributions of 1A2, 2E1 and 3A isoforms Tassaneeyakul, W.
McManus, M.E.
Tassaneeyakul, W.
1994 Biochemical Pharmacology
10 (47), pp. 1767-1776
8. Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene 1 Tassaneeyakul, W.
Tassaneeyakul, W.
1996 Journal of Pharmacology and Experimental Therapeutics
1 (276), pp. 101-108
9. Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice Tassaneeyakul, W.
Tassaneeyakul, W.
Vannaprasaht, S.
Yamazoe, Y.
2000 British Journal of Clinical Pharmacology
2 (49), pp. 139-144
10. Analysis of the CYP2C19 polymorphism in a North-eastern Thai population Tassaneeyakul, W.
Tawalee, A.
Tassaneeyakul, W.
Kukongviriyapan, V.
Blaisdell, J.A.
Goldstein, J.A.
,
2002 Pharmacogenetics
3 (12), pp. 221-225
11. Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C [4] Tassaneeyakul, W.
Srimarthpirom, S.
Reungjui, S.
Chansung, G.
Romphruk, A.V.
Tassaneeyakul, W.
2003 Transplantation
1 (76), pp. 265-266
12. Contamination of aflatoxins in herbal medicinal products in Thailand Tassaneeyakul, W.
Porasuphatana, S.
2004 Mycopathologia
2 (158), pp. 239-244
13. Thiopurine S-methyltransferase polymorphism in the Thai population Tassaneeyakul, W.
Kukongviriyapan, V.
Tassaneeyakul, W.
2004 British Journal of Clinical Pharmacology
1 (58), pp. 66-70
14. Steady-state bioequivalence study of clozapine tablet in schizophrenic patients Tassaneeyakul, W.
Kittiwattanagul, K.
Vannaprasaht, S.
Kampan, J.
Tawalee, A.
Puapairoj, P.
Taimkao, S.
Kukongviriyapan, V.
Tassaneeyakul, W.
2005 Journal of Pharmacy and Pharmaceutical Sciences
1 (8), pp. 47-53
15. CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations. Tassaneeyakul, W.
Mahatthanatrakul, W.
Niwatananun, K.
Na-Bangchang, K.
Tawalee, A.
Krikreangsak, N.
Cykleng, U.
Tassaneeyakul, W.
2006 Drug metabolism and pharmacokinetics
4 (21), pp. 286-290
16. Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis Jitpimolmard, S.
Sawanyawisuth, K.
Morakote, N.
Vejjajiva, A.
Puntumetakul, M.
Sanchaisuriya, K.
Tassaneeyakul, W.
Tassaneeyakul, W.
2007 Parasitology Research
6 (100), pp. 1293-1296
17. Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand Vannaprasaht, S.
Angsuthum, S.
Avihingsanon, Y.
Sirivongs, D.
Pongskul, C.
Makarawate, P.
Tassaneeyakul, W.
Tassaneeyakul, W.
2009 Clinical Therapeutics
7 (31), pp. 1524-1533
18. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population Tassaneeyakul, W.
Jantararoungtong, T.
Tiamkao, S.
Vannaprasaht, S.
Choonhakarn, C.
Pisuttimarn, P.
Tassaneeyakul, W.
2009 Pharmacogenetics and Genomics
9 (19), pp. 704-709
19. Inhibitory effects of phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: Evidence for CYP3A4 mechanism-based Inhibition Taesotikul, T.
Dumrongsakulchai, W.
Wattanachai, N.
Tassaneeyakul, W.
Tassaneeyakul, W.
2011 Drug Metabolism and Pharmacokinetics
2 (26), pp. 154-161
20. In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: Effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance Wattanachai, N.
Uchaipichat, V.
Tassaneeyakul, W.
Tassaneeyakul, W.
2011 European Journal of Clinical Pharmacology
8 (67), pp. 815-824
21. Associations between HLA class i and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population Tassaneeyakul, W.
Kongpan, T.
Chumworathayi, P.
Tiamkao, S.
Nakkam, N.
Vannaprasaht, S.
Mahasirimongkol, S.
Tassaneeyakul, W.
2016 Pharmacogenetics and Genomics
5 (26), pp. 225-234
22. Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers Tassaneeyakul, W.
Nakkam, N.
Tiamkao, S.
Kanjanawart, S.
Phunikhom, K.
Tiamkao, S.
Vannaprasaht, S.
Tassaneeyakul, W.
2017 International Journal of Clinical Pharmacology and Therapeutics
2 (55), pp. 177-185
23. Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population Tassaneeyakul, W.
Nakkam, N.
Chumworathayi, P.
Chaiyakunapruk, N.
Sawanyawisuth, K.I.
Tassaneeyakul, W.
2017 Pharmacogenetics and Genomics
7 (27), pp. 255-263
24. HLA pharmacogenetic markers of drug hypersensitivity in a Thai population Nakkam, N
Kanjanawart, S.
Kongpan, T.
Tassaneeyakul, W.
2018 Frontiers in Genetics
AUG (9), pp.

Title Authors Year Journal title
1. Analysis of the CYP2C19 polymorphism in a North-eastern Thai population. Tassaneeyakul, W
Tawalee, A
Tassaneeyakul, W
Kukongviriyapan, V
Blaisdell, J
Goldstein, JA
Gaysornsiri, D
2002 Pharmacogenetics
3 (12), pp. 221-5
2. Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C. Tassaneeyakul, W
Srimarthpirom, S
Reungjui, S
Chansung, K
Romphruk, A
Tassaneeyakul, W
2003 Transplantation
1 (76), pp. 265-6
3. Thiopurine S-methyltransferase genetic polymorphism in the Thai population. Srimartpirom, S
Tassaneeyakul, W
Kukongviriyapan, V
Tassaneeyakul, W
2004 British journal of clinical pharmacology
1 (58), pp. 66-70
4. Contamination of aflatoxins in herbal medicinal products in Thailand. Tassaneeyakul, W
Razzazi-Fazeli, E
Porasuphatana, S
Bohm, J
2004 Mycopathologia
2 (158), pp. 239-44
5. Steady-state bioequivalence study of clozapine tablet in schizophrenic patients. Tassaneeyakul, W
Kittiwattanagul, K
Vannaprasaht, S
Kampan, J
Tawalee, A
Puapairoj, P
Tiamkao, S
Juthagridsada, S
Kukongviriyapan, V
Tassaneeyakul, W
2005 Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques
1 (8), pp. 47-53
6. CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations. Tassaneeyakul, W
Mahatthanatrakul, W
Niwatananun, K
Na-Bangchang, K
Tawalee, A
Krikreangsak, N
Cykleng, U
Tassaneeyakul, W
2006 Drug metabolism and pharmacokinetics
4 (21), pp. 286-90
7. Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis. Jitpimolmard, S
Sawanyawisuth, K
Morakote, N
Vejjajiva, A
Puntumetakul, M
Sanchaisuriya, K
Tassaneeyakul, W
Tassaneeyakul, W
Korwanich, N
2007 Parasitology research
6 (100), pp. 1293-6
8. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. Tassaneeyakul, W
Jantararoungtong, T
Chen, P
Lin, PY
Tiamkao, S
Khunarkornsiri, U
Chucherd, P
Konyoung, P
Vannaprasaht, S
Choonhakarn, C
Pisuttimarn, P
Sangviroon, A
Tassaneeyakul, W
2009 Pharmacogenetics and genomics
9 (19), pp. 704-9
9. Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand. Vannaprasaht, S
Angsuthum, S
Avihingsanon, Y
Sirivongs, D
Pongskul, C
Makarawate, P
Praditpornsilpa, K
Tassaneeyakul, W
Tassaneeyakul, W
2009 Clinical therapeutics
7 (31), pp. 1524-33
10. Inhibitory effects of Phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: evidence for CYP3A4 mechanism-based inhibition. Taesotikul, T
Dumrongsakulchai, W
Wattanachai, N
Navinpipat, V
Somanabandhu, A
Tassaneeyakul, W
Tassaneeyakul, W
2011 Drug metabolism and pharmacokinetics
2 (26), pp. 154-61
11. In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance. Wattanachai, N
Polasek, TM
Heath, TM
Uchaipichat, V
Tassaneeyakul, W
Tassaneeyakul, W
Miners, JO
2011 European journal of clinical pharmacology
8 (67), pp. 815-24
12. The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions. Nakkam, N
Tiamkao, S
Kanjanawart, S
Tiamkao, S
Vannaprasaht, S
Tassaneeyakul, W
Tassaneeyakul, W
2015 Drug metabolism and pharmacokinetics
4 (30), pp. 295-304
13. Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions. Kongpan, T
Mahasirimongkol, S
Konyoung, P
Kanjanawart, S
Chumworathayi, P
Wichukchinda, N
Kidkeukarun, R
Preechakul, S
Khunarkornsiri, U
Bamrungram, W
Supharatwattanakun, B
Mootsikapun, P
Kwangsukstid, S
Denjanta, S
Vannaprasaht, S
Rungapiromnan, W
Suwankesawong, W
Tassaneeyakul, W
Tassaneeyakul, W
2015 Pharmacogenetics and genomics
8 (25), pp. 402-11
14. Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population. Tassaneeyakul, W
Prabmeechai, N
Sukasem, C
Kongpan, T
Konyoung, P
Chumworathayi, P
Tiamkao, S
Khunarkornsiri, U
Kulkantrakorn, K
Saksit, N
Nakkam, N
Satapornpong, P
Vannaprasaht, S
Sangviroon, A
Mahasirimongkol, S
Wichukchinda, N
Rerkpattanapipat, T
Tassaneeyakul, W
2016 Pharmacogenetics and genomics
5 (26), pp. 225-34
15. Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population. Saksit, N
Tassaneeyakul, W
Nakkam, N
Konyoung, P
Khunarkornsiri, U
Chumworathayi, P
Sukasem, C
Suttisai, S
Piriyachananusorn, N
Tiwong, P
Chaiyakunapruk, N
Sawanyawisuth, K
Rerkpattanapipat, T
Tassaneeyakul, W
2017 Pharmacogenetics and genomics
7 (27), pp. 255-263
16. Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers
. Nakkam, N
Tiamkao, S
Kanjanawart, S
Phunikhom, K
Tiamkao, S
Vannaprasaht, S
Tassaneeyakul, W
Tassaneeyakul, W
2017 International journal of clinical pharmacology and therapeutics
2 (55), pp. 177-185
17. Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population. Nakkam, N
Konyoung, P
Kanjanawart, S
Saksit, N
Kongpan, T
Khaeso, K
Khunarkornsiri, U
Dornsena, A
Tassaneeyakul, W
Tassaneeyakul, W
2018 Frontiers in genetics
(9), pp. 277

Title Authors Year Journal title Cited count
< 2015 2016 2017 2018 2019 2020 Total
1. Analysis of the CYP2C19 polymorphism in a North-eastern Thai population A Tawalee
W Tassaneeyakul
V Kukongviriyapan
J Blaisdell
JA Goldstein
D Gaysornsiri
2002 PHARMACOGENETICS
3.0 (12.0), pp. 221.0-225.0
57 0 0 0 0 0 57
2. Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C S Srimarthpirom
S Reungjui
K Chansung
A Romphurk
W Tassaneeyakul
2003 TRANSPLANTATION
1.0 (76.0), pp. 265.0-266.0
38 0 0 0 0 0 38
3. Prevalence and strain distribution of HPV in cervical cancer patients of northeastern Thailand W Settheetham-Ishida
Y Singto
N Kanjanavirojkul
P Yuenyao
W Tassaneeyakul
S Luanratanakorn
C Kularbkaew
T Ishida
2003 JOURNAL OF CLINICAL VIROLOGY
(28.0), pp. S102-S102
0 0 0 0 0 0 0
4. Contamination of aflatoxins in herbal medicinal products in Thailand W Tassaneeyakul
E Razzazi-Fazeli
S Porasuphatana
J Bohm
2004 MYCOPATHOLOGIA
2.0 (158.0), pp. 239.0-244.0
91 0 0 0 0 0 91
5. Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in Northeastern Thailand W Settheetham-Ishida
Y Singto
P Yuenyao
W Tassaneeyakul
N Kanjanavirojkul
T Ishida
2004 CANCER LETTERS
2.0 (210.0), pp. 205.0-211.0
41 0 0 0 0 0 41
6. Thiopurine S-methyltransferase genetic polymorphism in the Thai population S Srimartpirom
V Kukongviriyapan
W Tassaneeyakul
2004 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
1.0 (58.0), pp. 66.0-70.0
45 0 0 0 0 0 45
7. Assessment of the CYP1A2 & CYP2E1 activities in thalassemia patients V Kukongviriyapan
N Somparn
L Senggunprai
U Kukongviriyapan
W Tassaneeyakul
A Jetsrisuparb
2005 FASEB JOURNAL
4.0 (19.0), pp. A541-A542
0 0 0 0 0 0 0
8. Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma A Prawan
V Kukongviriyapan
W Tassaneeyakul
C Pairojkul
V Bhudhisawasdi
2005 EUROPEAN JOURNAL OF CANCER PREVENTION
3.0 (14.0), pp. 245.0-250.0
54 0 0 0 0 0 54
9. Steady-state bioequivalence study of clozapine tablet in schizophrenic patients K Kittiwattanagul
S Vannaprasaht
J Kampan
A Tawalee
P Puapairoj
S Tiamkao
S Juthagridsada
V Kukongviriyapan
W Tassaneeyakul
2005 JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
1.0 (8.0), pp. 47.0-53.0
18 0 0 0 0 0 18
10. CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations Wichittra Tassaneeyakul
Werawath Mahatthanatrakul
Kanokporn Niwatananun
Kesara Na-Bangchang
Arporn Tawalee
Nathawut Krikreangsak
Utaiwan Cykleng
Wongwiwat Tassaneeyakul
2006 DRUG METABOLISM AND PHARMACOKINETICS
4.0 (21.0), pp. 286.0-290.0
46 0 0 0 0 0 46
11. Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2 V Kukongviriyapan
N Phromsopha
W Tassaneeyakul
U Kukongviriyapan
B Sripa
V Hahnvajanawong
V Bhudhisawasdi
2006 XENOBIOTICA
1.0 (36.0), pp. 15.0-28.0
37 0 0 0 0 0 37
12. Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis Suthipun Jitpimolmard
Kittisak Sawanyawisuth
Nimit Morakote
Athasit Vejjajiva
Montien Puntumetakul
Kanokwan Sanchaisuriya
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
Narumanas Korwanich
2007 PARASITOLOGY RESEARCH
6.0 (100.0), pp. 1293.0-1296.0
77 0 0 0 0 0 77
13. ALPHA-LIPOIC ACID INCREASES REACTIVE OXYGEN SPECIES GENERATION AND REDUCED GLUTATHIONE IN AFLATOXINB1-EXPOSED HEPG2 CELL LINE Nattakorn Rangsoi
Supatra Porasuphatana
Pramote Mahakunakorn
Wongwiwat Tassaneeyakul
2007 DRUG METABOLISM REVIEWS
(39.0), pp. 150.0-150.0
0 0 0 0 0 0 0
14. COMPARATIVE BIOAVAILABILITY OF TWO SILDENAFIL TABLET FORMULATIONS AFTER SINGLE-DOSE ADMINISTRATION IN HEALTHY THAI MALE VOLUNTEERS Sirimas Kanjanawart
Suda Vannaprasaht
Panot Tangsucharit
Dhanu Gaysornsiri
Siriporn Tiamkao
Bunkerd Kongyingyoes
Roongpet Tangrassameeprasert
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2007 DRUG METABOLISM REVIEWS
(39.0), pp. 87.0-87.0
0 0 0 0 0 0 0
15. INHIBITORY EFFECT OF THAI MEDICINAL HERBS ON HUMAN CYTOCHROME P450 ACTIVITIES Wichittra Tassaneeyakul
Weeraya Dumrongsakunchai
Vichien Attakornvattana
Aimon Somanabandhu
Suda Vannaprasaht
Wongwiwat Tassaneeyakul
2007 DRUG METABOLISM REVIEWS
(39.0), pp. 219.0-219.0
0 0 0 0 0 0 0
16. THIOPURINE S-METHYLTRANSFERASE POLYMORPHISM AS A PREDICTIVE MARKER FOR AZATHIOPRINE-INDUCED HEMATOTOXICITY IN KIDNEY TRANSPLANT RECIPIENTS Susothorn Angsuthum
Wichittra Tassaneeyakul
Cholatip Pongskul
Dhavee Sirivongs
Wongwiwat Tassaneeyakul
Yingyos Avihingsanon
Suda Vannaprasaht
2007 DRUG METABOLISM REVIEWS
(39.0), pp. 269.0-269.0
0 0 0 0 0 0 0
17. Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism U. Boonsrirat
S. Angsuthum
S. Vannaprasaht
J. Konapurivijit
N. Hirankarn
W. Tassaneeyakul
Y. Avihingsanon
2008 LUPUS
2.0 (17.0), pp. 132.0-134.0
31 0 0 0 0 0 31
18. Comparative bioavailability of two sertraline tablet formulations after single-dose administration in healthy Thai volunteers W. Tassaneeyakul
S. Kanchanawat
D. Gaysonsiri
S. Vannaprasath
R. Paupairoj
K. Kittiwattanagul
S. K. Tippabhotla
A. Khuroo
B. K. Panigrahy
S. Reyar
T. Monif
2008 INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
3.0 (46.0), pp. 151.0-156.0
2 0 0 0 0 0 2
19. Bioequivalence study of two meloxicam tablet formulations after single-dose administration in healthy Thai male volunteers P. Tangsucharit
J. Kampan
S. Kanjanawart
D. Gaysonsiri
S. Vannaprasaht
S. Tiamkao
K. Phunikhom
S. Simasathiansophon
P. Puapairoj
W. Tassaneeyakul
2009 INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
10.0 (47.0), pp. 638.0-642.0
8 0 0 0 0 0 8
20. Impact of the Heterozygous TPMT*1/*3C Genotype on Azathioprine-Induced Myelosuppression in Kidney Transplant Recipients in Thailand Suda Vannaprasaht
Susothorn Angsuthum
Yingyos Avihingsanon
Dhavee Sirivongs
Cholatip Pongskul
Pattarapong Makarawate
Kearkiat Praditpornsilpa
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2009 CLINICAL THERAPEUTICS
7.0 (31.0), pp. 1524.0-1533.0
22 0 0 0 0 0 22
21. Inhibition- and Mechanism-based Inactivation of Human CYP3A4 BY Phyllanthus amarus Theerada Taesotikul
Aimon Somanabandhu
Vichien Navinpipatana
Sirimas Kanjanawart
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2009 DRUG METABOLISM REVIEWS
(41.0), pp. 39.0-39.0
0 0 0 0 0 0 0
22. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population Wichittra Tassaneeyakul
Thawinee Jantararoungtong
Pei Chen
Pao-Yu Lin
Somsak Tiamkao
Usanee Khunarkornsiri
Pachadaporn Chucherd
Parinya Konyoung
Suda Vannaprasaht
Charoen Choonhakarn
Pornrith Pisuttimarn
Alisara Sangviroon
Wongwiwat Tassaneeyakul
2009 PHARMACOGENETICS AND GENOMICS
9.0 (19.0), pp. 704.0-709.0
345 0 0 0 0 0 345
23. Allopurinol -induced severe cutaneous adverse drug reactions in a Thai population is strongly associated with HLA-B*5801 Wongwiwat Tassaneeyakul
Somsak Tiamkao
Napat Prabmeechai
Thawinee Jantararoungtong
Pei Chen
Pao-Yu Lin
Pansu Chumworathayi
Usanee Khunarkornsiri
Parinya Konyoung
Pachadaporn Chucherd
Suda Vannaprasaht
Charoen Choonhakarn
Alisara Sangviroon
Wichittra Tassaneeyakul
2010 DRUG METABOLISM REVIEWS
(42.0), pp. 253.0-254.0
0 0 0 0 0 0 0
24. Comparative bioavailability of two risperidone orodispersible tablet products after single dose administration W. Tassaneeyakul
S. Kumar
D. Gaysonsiri
T. Kaewkamson
A. Khuroo
P. Tangsucharit
K. Phunikhom
S. Vannaprasaht
S. Kanjanawart
N. Rao Thudi
R. Jain
S. Reyar
T. Monif
2010 INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
9.0 (48.0), pp. 614.0-620.0
2 0 0 0 0 0 2
25. THIOPURINE S- METHYLTRANSFERASE PHARMACOGENETICS: FUNCTIONAL CHARACTERIZATION OF A NOVEL RAPIDLY DEGRADED VARIANT ALLOZYME. Q. Feng
S. Vannaprasaht
Y. Peng
S. Angsuthum
Y. Avihingsanon
V. C. Yee
W. Tassaneeyakul
R. M. Weinshilboum
2010 CLINICAL PHARMACOLOGY & THERAPEUTICS
(87.0), pp. S6-S6
0 0 0 0 0 0 0
26. WHAT COST OF HLA-B*5801 GENOTYPING WOULD BE COST-EFECTIVE FOR THE PREVENTION OF ALLOPURINOL-INDUCED STEVENS JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS IN THAILAND: ANALYSES USING A DECISION-ANALYTIC MODEL R. Somkrua
N. Chaiyakunapruk
W. Tassaneeyakul
2010 VALUE IN HEALTH
7.0 (13.0), pp. A564-A565
4 0 0 0 0 0 4
27. Comparative bioavailability of two sildenafil tablet formulations after single-dose administration in healthy Thai male volunteers S. Kanjanawart
D. Gaysonsiri
P. Tangsucharit
S. Vannaprasaht
K. Phunikhom
T. Kaewkamson
N. Wattanachai
W. Tassaneeyakul
2011 INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
8.0 (49.0), pp. 525.0-530.0
18 0 0 0 0 0 18
28. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases N. Namwat
J. Puetkasichonpasutha
W. Loilome
P. Yongvanit
A. Techasen
A. Puapairoj
B. Sripa
W. Tassaneeyakul
N. Khuntikeo
S. Wongkham
2011 JOURNAL OF GASTROENTEROLOGY
5.0 (46.0), pp. 664.0-675.0
53 0 0 0 0 0 53
29. Inhibitory Effects of Phyllanthus amarus and Its Major Lignans on Human Microsomal Cytochrome P450 Activities: Evidence for CYP3A4 Mechanism-Based Inhibition Theerada Taesotikul
Weeraya Dumrongsakulchai
Nitsupa Wattanachai
Vichien Navinpipat
Aimon Somanabandhu
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2011 DRUG METABOLISM AND PHARMACOKINETICS
2.0 (26.0), pp. 154.0-161.0
36 0 0 0 0 0 36
30. In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6 alpha-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance Nitsupa Wattanachai
Thomas M. Polasek
Tahlia M. Heath
Verawan Uchaipichat
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
John O. Miners
2011 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
8.0 (67.0), pp. 815.0-824.0
46 0 0 0 0 0 46
31. EVIDENCE SYNTHESIS OF ASSOCIATION OF HLA-B*1502 ALLELE AND CARBAMAZEPINE -INDUCED STEVENS JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS: A SYSTEMATIC REVIEW W. Tangamornsuksan
N. Chaiyakunapruk
R. Somkrua
M. Lohitnavy
W. Tassaneeyakul
2012 VALUE IN HEALTH
7.0 (15.0), pp. A640-A640
0 0 0 0 0 0 0
32. Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing M. S. Hershfield
J. T. Callaghan
W. Tassaneeyakul
T. Mushiroda
C. F. Thorn
T. E. Klein
M. T. M. Lee
2013 CLINICAL PHARMACOLOGY & THERAPEUTICS
2.0 (93.0), pp. 153.0-158.0
134 0 0 0 0 0 134
33. SCN5A (H558R) gene mutation is associated with appropriate shock therapy in Thai Brugada syndrome patients receiving AICD treatment P. Makarawate
N. Chaosuwannakit
S. Vannaprasaht
K. Sawanyawisuth
K. Seok Hwee
E. Deoon Lee
W. Tassaneeyakul
2013 EUROPEAN HEART JOURNAL
(34.0), pp. 424.0-424.0
0 0 0 0 0 0 0
34. Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions Thachanan Kongpan
Surakameth Mahasirimongkol
Parinya Konyoung
Sirimas Kanjanawart
Pansu Chumworathayi
Nuanjun Wichukchinda
Runglak Kidkeukarun
Suphanlinee Preechakul
Usanee Khunarkornsiri
Warawut Bamrungram
Butsaban Supharatwattanakun
Piroon Mootsikapun
Supanida Kwangsukstid
Sukanda Denjanta
Suda Vannaprasaht
Watcharee Rungapiromnan
Wimon Suwankesawong
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2015 PHARMACOGENETICS AND GENOMICS
8.0 (25.0), pp. 402.0-411.0
39 1 0 0 0 0 40
35. Genetic Determinants of Antiplatelet Aggregation Response to Clopidogrel Under Steady State Condition N. Nakkam
S. Kanjanawart
S. Tiamkao
W. Tassaneeyakul
2015 PUBLIC HEALTH GENOMICS
(18.0), pp. 11.0-11.0
0 0 0 0 0 0 0
36. Genetic Markers for Severe Cutaneous Adverse Drug Reactions of Phenytoin S. Tiamkao
N. Prabmeechai
P. Konyoung
P. Chumworathayi
C. Sukasem
T. Kongpan
N. Saksit
A. Sangviroon
S. Vannaprasath
S. Kanjanawat
N. Wichukchinda
S. Mahasirimongkol
W. Inunchot
N. Chaiyakunapruk
W. Tassaneeyakul
2015 PUBLIC HEALTH GENOMICS
(18.0), pp. 5.0-5.0
0 0 0 0 0 0 0
37. The Effect of Genetic Polymorphism of CYP2C9 on Phenytoin Dosage Requirement in Thai Epileptic Patients S. Vannaprasaht
P. Sirisawat
P. Chiewthanakul
S. Tiamkao
W. Tassaneeyakul
2015 PUBLIC HEALTH GENOMICS
(18.0), pp. 13.0-14.0
0 0 0 0 0 0 0
38. The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions Nontaya Nakkam
Somsak Tiamkao
Sirimas Kanjanawart
Siriporn Tiamkao
Suda Vannaprasaht
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2015 DRUG METABOLISM AND PHARMACOKINETICS
4.0 (30.0), pp. 295.0-304.0
6 0 0 0 0 0 6
39. Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population Wichittra Tassaneeyakul
Napat Prabmeechai
Chonlaphat Sukasem
Thachanan Kongpan
Parinya Konyoung
Pansu Chumworathayi
Somsak Tiamkao
Usanee Khunarkornsiri
Kongkiat Kulkantrakorn
Niwat Saksit
Nontaya Nakkam
Patompong Satapornpong
Suda Vannaprasaht
Alisara Sangviroon
Surakameth Mahasirimongkol
Nuanjun Wichukchinda
Ticha Rerkpattanapipat
Wongwiwat Tassaneeyakul
2016 PHARMACOGENETICS AND GENOMICS
5.0 (26.0), pp. 225.0-234.0
65 0 0 0 0 0 65
40. Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers Nontaya Nakkam
Somsak Tiamkao
Sirimas Kanjanawart
Kutcharin Phunikhom
Siriporn Tiamkao
Suda Vannaprasaht
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2017 INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
2.0 (55.0), pp. 177.0-185.0
0 0 0 0 0 0 0
41. Comparison between the HLA-B*58: 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions Niwat Saksit
Nontaya Nakkam
Parinya Konyoung
Usanee Khunarkornsiri
Wongwiwat Tassaneeyakul
Pansu Chumworathayi
Sirimas Kanjanawart
Chonlaphat Sukasem
Alisara Sangviroon
Oranuch Pattanacheewapull
Wichittra Tassaneeyakul
2017 JOURNAL OF IMMUNOLOGY RESEARCH
(), pp.
4 0 0 0 0 0 4
42. CYP2C9*3 VARIANT IS ASSOCIATED WITH PHENYTOIN-RELATED SEVERE CUTANEOUS ADVERSE REACTIONS IN A THAI POPULATION Wichittra Tassaneeyakul
Parinya Konyoung
Thachanan Kongpan
Pansu Chumworathayi
Nontaya Nakkam
Suda Vannaprasaht
Somsak Tiamkao
Chonlaphat Sukasem
Patompong Satapornpong
Wongwiwat Tassaneeyakul
2017 DRUG METABOLISM AND PHARMACOKINETICS
1.0 (32.0), pp. S85-S86
0 0 0 0 0 0 0
43. Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population Niwat Saksit
Wichittra Tassaneeyakul
Nontaya Nakkam
Parinya Konyoung
Usanee Khunarkornsiri
Pansu Chumworathayi
Chonlaphat Sukasem
Sumitra Suttisai
Napacha Piriyachananusorn
Pawinee Tiwong
Nathorn Chaiyakunapruk
Kittisak Sawanyawisuth
Ticha Rerkpattanapipat
Wongwiwat Tassaneeyakul
2017 PHARMACOGENETICS AND GENOMICS
7.0 (27.0), pp. 255.0-263.0
12 0 0 0 0 0 12
44. HLA Pharmacogenetic Markers o Drug Hypersensitivity in a Thai Population Nontaya Nakkam
Parinya Konyoung
Sirimas Kanjanawart
Niwat Saksit
Thachanan Kongpan
Kanyarat Khaeso
Usanee Khunarkornsiri
Areerat Domsena
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2018 FRONTIERS IN GENETICS
(9.0), pp.
2 0 0 0 0 0 2

Title Authors Year Journal title
1. Towards Understanding Cytochromes P450 Wichittra Tassaneeyakul
Wongwiwat Tassaneeyakul
Khan Kaen Khon Kaen University
1996 Thai Journal of Pharmacology
(18), pp. 43-65
2. Genetic Polymorphism of Cytochrome P450 2C19 (CYP2CL9) in The Northeastern Thai Population Wichittra Tassaneeyakul
Arpom Tawalee
Veerapol Kukongviriyapan
Wongwiwat Tassaneeyakul
2000 Thai Journal of Pharmacology
Supplement 1 (22), pp. S79
3. Genetic Polymorphism of Cytochrome P450 2C19 Wichittra Tassaneeyakul
Arporn Tawalee
Wongwiwat Tassaneeyakul
2000 Thai Journal of Pharmacology
(22 No 2), pp. 121-136
4. Genetic Polymorphism of Thiopurine S-Methyltransferase in a Northeastern Thai Population Somrudee Srimartpirom
Wongwiwat Tassaneeyakul
Veerapol Kukongwiriyapan
Wichittra Tassaneeyakul
2002 Thai Journal of Pharmacology
Supplement 1 (24), pp. 137
5. Bioequivalence Study of Ceftazidime by Intramuscular Administration in Healthy Thai Volunteers Wongwiwat Tassaneeyakul
Arporn Tawalee
Watchara Boonsawat
Katcharin Phunikom
Veerapol Kukongviriyapan
Prapawadee Puapairoj
Wichittra Tassaneeyakul
2002 Srinagarind Medical Journal
(17 No 4), pp. 254-260
6. Bioequivalence of Clozapine Tablet in Thai Schizophrenic Patients Wichittra Tassaneeyakul
Khanogwan Kittiwattanagul
Siriporn Tiamkao
Jureeporn Kampan
Suda Vannaprasaht
Wannapa Haewdee
Prapawadee Puapairoj
Bunkerd Kongyingyoes
Wongwiwat Tassaneeyakul
2007 Srinagarind Medical Journal
(22 No 1), pp. 16-23
7. Herb and Drug Interaction Wichittra Tassaneeyakul
Weeraya Dumrongsakunchai
Wongwiwat Tassaneeyakul
2008 Srinagarind Medical Journal
(23 No 2), pp. 223-228
8. Study on Cytotoxicity and Genotoxicity of Repeatedly Fried Cooking Oils by Cell Culture Jetana Weerakul
Wongwiwat Tassaneeyakul
Pramote Mahakunakorn
Supattra Porasuphatana
2009 Isan Journal of Pharmaceutical Sciences
(5 No 3), pp. 235-242

Title Authors NRIIS type Year NRIIS Scholarship

0.06220865249633789